Pericytes surround capillary endothelial cells and exert contractile forces modulating microvascular tone and endothelial growth. We previously described pericyte contractile phenotype to be Rho GTPase-and α-smooth muscle actin (αSMA)-dependent. However, mechanisms mediating adhesion-dependent shape changes and contractile force transduction remain largely equivocal. We now report that the neutral cysteine protease, calpain, modulates pericyte contractility and cellular stiffness via talin, an integrin-binding and F-actin associating protein. Digital imaging and quantitative analyses of living cells reveal significant perturbations in contractile force transduction detected via deformation of silicone substrata, as well as perturbations of mechanical stiffness in cellular contractile subdomains quantified via atomic force microscope (AFM)-enabled nanoindentation. Pericytes overexpressing GFP-tagged talin show significantly enhanced contractility (~two-fold), which is mitigated when either the calpain-cleavage resistant mutant talin L432G or vinculin are expressed. Moreover, the cell-penetrating, calpain specific inhibitor termed CALPASTAT reverses talin-enhanced, but not Rho GTP-dependent, contractility. Interestingly, our analysis revealed that CALPASTAT, but not its inactive mutant, alters contractile cell-driven substrata deformations while increasing mechanical stiffness of subcellular contractile regions of these pericytes. Altogether, our results reveal that calpain-dependent cleavage of talin modulates cell contractile dynamics, which in pericytes may prove instrumental in controlling normal capillary function or microvascular pathophysiology.
Introduction
Regulation of microvascular remodeling during physiologic and pathologic angiogenesis involves multiple, dynamic interactions between endothelial cells (EC) and pericytes (Jain 2003; Folkman 1971; Kutcher and Herman 2009 ). Pericytes surround the capillary endothelium, communicating directly through the basement membrane via gap junctions or soluble factors: these interactions modulate microvascular stability, angiogenesis, capillary contractility and blood flow (Kutcher and Herman 2009; Darland and D'Amore 1999; Rucker et al 2000) . Indeed, pericyte-EC associations have been demonstrated to regulate vascular maturation (Darland and D'Amore 2001a) , and it has been conclusively established that soluble mediators and pericyte contacts control EC growth and survival via TGF-beta and VEGF (Darland and D'Amore 2001b; Darland et al 2003; Shih et al 2003; Sieczkiewicz and Herman 2003; Papetti et al 2003) . Reciprocally, ECs are postulated to recruit and maintain differentiated pericytes in the microvascular niche via growth factors including FGF-2 (Healy and Herman 1992) and PDGF (Bjarnegard et al 2004; Wilkinson-Berka et al 2004) . Such pericyte-EC interactions modulate EC proliferation (Orlidge and D'Amore 1987) and migration (Sato and Rifkin 1989) , prevent microvascular regression (Benjamin, Hemo and Keshet 1998) , and can stabilize nascent microvessels during development (von Tell, Armulik and Betsholtz 2006) . Finally, we have recently demonstrated that pericyte contraction is sufficient to modulate the mechanical niche of adjacent EC, either via direct contractile strain or indirect modulation of the mechanical stiffness of strained basement membrane (Lee et al 2010) . Thus, it is becoming increasingly apparent that pericytes play key regulatory roles in modulating microvascular remodeling, capillary contractility and blood flow.
Pericyte control of microvascular remodeling and capillary tonus has been implicated as dependent on Rho GTP, Rho kinase, and isoactin (Kutcher and Herman 2009; Kolyada, Riley and Herman 2003; Kutcher et al 2007) . Indeed, previous studies have revealed that signaling through pericyte Rho GTP enhances pericyte contractility specifically through the α-smooth muscle actin (αSMA) cytoskeletal network. Furthermore, pericyte control of EC proliferation is similarly sensitive to pericyte-dependent contractility, since modulating pericyte Rho GTP reversibly regulates endothelial growth regardless of whether pericytes and EC are in direct cell contact (Kutcher et al 2007) . In this way, pericyte mechanotransduction may prove instrumental in modulating EC growth during pathologic angiogenesis that would not depend on "pericyte dropout" or death as the initiating signal/event (Kutcher and Herman 2009; Kutcher et al 2007) .
If mechanical force transduction plays an instrumental role in regulating endothelial dynamics during physiologic or pathologic angiogenesis, then one might posit that the key interface of interest is the cell membrane, which links the cytoskeleton to the extracellular matrix or adjacent cells through specific adhesive ligand-receptor complexes. Indeed, macromolecular focal adhesion complexes or FAs coordinate such dynamic interactions and participate in force transduction. Transmembrane integrins are key FA components that act as adhesion receptors via binding to extracellular matrix (ECM) ligands (Hynes 2002; Berrier and Yamada 2007) . These integrins cluster in a calpain-dependent manner (Bialkowska et al 2000) ; the active remodeling of these FA-cytoskeletal protein assemblies occurs by recruiting cytoskeletal actin adaptors and regulators via β-integrin cytoplasmic tails. Key adaptor proteins include vinculin, α-actinin, paxillin, zyxin and talin (Zamir and Geiger 2001; Zaidel-Bar et al 2007) . Among these FA components, talin 1 not only binds and activates integrins (Banno and Ginsberg 2008; Wegener et al 2007; Moes et al 2007) , but also binds to F-actin (Gingras et al 2008) , providing a direct link between the ECM and cytoskeleton. Talin 1 increasingly binds to vinculin under applied mechanical strain, and signals cytoskeletal remodeling (Izard and Vonrhein 2004; del Rio et al 2009) . Consequently, talin 1 is considered a key player in FA mechanosensory function, coordinating cell adhesion and supporting mechanotransduction while reinforcing integrin-cytoskeletal interactions Arnaout, Goodman and Xiong 2007; Roberts and Critchley 2009; Roca-Cusachs et al 2009) .
Previous studies have suggested that FA remodeling, including talin's role in coordinating membrane-cytoskeleton interactions, is regulated by the calcium-dependent protease, calpain (Franco et al 2004; Franco and Huttenlocher 2005) . This family of proteases is broadly implicated in cellular processes such as proliferation, differentiation, apoptosis, adhesion, spreading, migration and angiogenesis (Croall and Ersfeld 2007; Goll et al 2003; Ma et al 2009) , as well as in pathologies such as retinal degeneration (Paquet-Durand, Johnson and Ekstrom 2007; Azuma and Shearer 2008) and cancer cell invasion (Cortesio et al 2008) . Activity of two major isoforms, calpain 1 and calpain 2, is tightly regulated in a spatially and temporally specific fashion by phosphorylation, calcium binding-requirement, and by a specific cellular inhibitor, calpastatin (Franco and Huttenlocher 2005; Hanna, Campbell and Davies 2008) . Indeed, others have demonstrated the key roles that calpains play in modulating cytoskeletal dynamics during cell spreading and migration (Shuster and Herman 1995; Huttenlocher et al 1997; Croce et al 1999; Potter et al 1998) . In addition, calpain is required for the formation of nascent integrin clusters, which evolve into active Rac-containing focal complexes and into active RhoA-containing FAs (Kulkarni et al 1999) . More recently, it has been shown that the FA dynamics are regulated by calpain cleavage of talin, since expression of the calpain-resistant talin mutant L432G perturbs FA protein turnover (Franco et al 2004) .
Considering the pivotal role of pericytes in modulating microvascular morphogenesis in vivo, the connection between pericyte contraction and EC proliferation in vitro, and finally the regulation of FA dynamics by calpain, we have become interested in exploring the mechanisms that calpain may play in pericyte contractile force and, in turn, capillary contractility. Here, we report a series of experiments designed to test directly whether talin and calpain have the ability to regulate pericyte contractility. Using purified populations of bovine retinal pericytes and a deformable silicone substratum contractility assay, we compared the contractile phenotype of pericytes overexpressing GFP-tagged talin with those bearing a talin L432G mutant that is resistant to calpain cleavage. In related experiments, we quantified the influence of overexpressed vinculin and constitutively activated RhoA Q63L on pericyte contractility. Finally, to explore the molecular mechanisms controlling pericyte contractility in response to talin and RhoGTP-dependent signaling, we conducted atomic force microscopy (AFM)-enabled nanoindentation to quantify the subcellular stiffness of pericytes in situ, in the presence of a cell-penetrating calpain-specific inhibitor developed in our laboratory, termed CALPASTAT, and its inactive point mutant (Croce et al 1999) . Together, these experiments demonstrate that calpain-mediated signaling, in concert with talin, is a critical component of interactions at the pericyte cytoskeleton-membrane interface that regulate cell contractility and local cell stiffness. In turn, these observations may lend important insights into the manner in which chemomechanical force transduction and cytoskeletal-membrane signaling networks coordinate microvascular phenomena during development or disease.
Materials and Methods

Cell Culture
Primary cultures of bovine retinal pericytes (BRP) were isolated and characterized as described previously (Herman and D'Amore 1985) . Vascular smooth muscle actin (SMA)-, NG2 proteoglycan-and 3G5-positive and CD-31-and di-I-acyl-LDL-negative pericyte cultures were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with penicillin, streptomycin, Fungizone (all from Invitrogen, Carlsbad, CA) and 10% calf serum (CS, from Atlanta Biologicals. Lawrenceville, GA), and used for experiments between passage 2 and 4. Pericytes were grown in tissue culture plasticware (Corning, Inc., Corning, NY): T175 flasks (for expansion prior to experiments) and vessels of 24-well plate or 8-chamber slide format (for experiments proper), in a total volume of 1 ml per well or 0.5 ml per chamber, while incubated at 37°C in 5% CO 2 atmosphere.
Plasmids
The following plasmids were used: pEGFP-C1 empty vector (Clontech Inc., USA) expressing enhanced green fluorescent protein, EGFP-C1 fusion with mouse talin 1 and talin 1 mutant L432G (courtesy of Dr. A. Huttenlocher, University of Wisconsin-Madison), EGFP-C1 fusion with vinculin (courtesy of Dr. Susan Craig, Johns Hopkins University), pExv and pExv/RhoA (Q63L) expressing dominant active form of RhoA (RhoDA) (courtesy of Dr. Deniz Toksoz, Tufts University). Plasmid DNAs were prepared with endotoxin-free maxi kits (Qiagen).
Electroporation
One day before electroporation, pericytes were seeded at the density of 0.5 -0.7 × 10 6 pericytes per T175, to obtain ca. 60-70 % confluency on the next day. The electroporation mixture was prepared a 1.5 ml tube by including (per sample) 18 µl of supplement and 82 µl of solution (both from Basic Nucleofactor Kit for Primary Endothelial Cells, Lonza, Cat. No. VpI-1001), 15 µg of plasmids expressing EGFP fusion constructs or 12 µg of RhoA Q63L plasmid mixed with 3 µg of pEGFP-C1 plasmid (4:1 ratio). This mixture (110-120 µl) was added to 0.5 -1 × 10 6 pericytes, which were freshly harvested (trypsinized, counted in hemacytometer, washed and spun in 10 ml of growing medium in 15 ml conical tubes, in a bench top Sorvall RT6000B centrifuge at 700 rpm, 10 min at room temperature). Cells gently re-suspended in electroporation mixture were transferred to individual 4 mm electroporation cuvettes and electroporated using Harvard Apparatus BTX electroporator set for 2 pulses of 5 milliseconds each at 200 V, with an interval of 1 second. Five minutes after electroporation, 0.5 ml of growing medium was added to each cuvette with electroporated cells, and the whole volume was transferred to 15 ml tube, raised with growing medium to an appropriate volume and dispensed into duplicate experimental culture vessels. Using these constructs, electroporationoptimized transfection efficiently yields up to 45% GFP-positive cellular transfectants as ascertained by flow cytometry vs. 2-10% transfectants typically achieved using standard cationic lipid-based transfection reagents. Only electorporation was used as a method to obtain data from experiments involving overexpression of proteins in the bovine primary pericytes in this study.
Analysis of Pericyte Contractile Phenotype
Preparation of Deformable Silicone Substrates-Deformable silicone substrata for analysis of pericyte contractility in cultures were prepared as described previously (Harris et al, 1980; Kutcher et al., 2007) with the following modifications. Eight µl of silicone (dimethylpolysiloxane, Sigma cat. # DMPS12M-100G) was pipetted with a positive displacement pipette to spread for 1 hr at 42°C onto round 12 mm glass coverslips or chambers of 8-chamber glass culture slide, from which plastic dividers were removed. Silicone on glass coverslips or slides was thermally crosslinked by passing through a Bunsen burner flame. A glow plasma discharge apparatus (Aebi and Pollard, 1987) was used to generate a plasma discharge onto silicone-coated coverslips or chamber slides (1 min vacuum pump, followed by 1 min discharge). After re-assembling plastic dividers onto glass culture slides or placing coverslips into wells of a 24-well plate, the charged silicone surface was coated with 100 µl of 0.1 mg/ml Type I collagen (BD Biosciences) in PBS and UV irradiated for 3 min in a sterile hood, enabling subsequent cell attachment in the transiently hydrophilic environment. Approximately 2 -4 × 10 3 cells in 0.5 ml of growing medium were seeded onto prepared silicone coated coverslips or chamber slides and cultured for 24 hours prior to experiments unless otherwise noted.
Quantification of Contractile Force Production in Pericytes-On the next day after seeding, silicone-attached pericytes within 8-chamber culture slides or 24-well plates were examined via optical microscopy. Samples were mounted onto the motorized Ludl stage of a Zeiss Axiovert 200M computer-assisted light microscope imaging workstation within a 37°C stabilized, temperature-controlled environment, to enable live cell viewing for protracted periods of time. Corresponding phase-contrast and fluorescent microscopic images were acquired and overlaid for morphometric analysis using Metamorph software (Universal Imaging Corp.). Pericyte deformation of silicone substratum was scored as a manifestation of the cell contractile phenotype. In order to quantify the contractile phenotype of the cells, we defined an original parameter, designated as Cell Contractility Index (CCI), which describes the extent of contraction in terms of number and length of substrata wrinkles per cell. We define CCI as the normalized wrinkle index (WI experimental sample /WI control ). We define this wrinkle index as a weighted average of long and short wrinkles per actively contracting cell: WI = (W L + 0.5 x W S ) / n, where W L is the number of long wrinkles (spanning more than half of the cell width at the wrinkle location), W S is the number of short wrinkles (spanning less than half the cell width), and n is the number of actively contracting cells analyzed in a given culture condition. Actively contracting cells were those cells that visibly wrinkled the silicone substrata at the instance of WI measurement (24 hrs unless otherwise stated). Note that short wrinkles were generally observed less frequently than long ones, and we corrected for the apparently lower magnitude of contractile force at short wrinkles by halving this contribution to WI. In experiments with transfected EGFP plasmids, CCI was analyzed in contracting cells expressing EGFP fusion proteins. The normalized wrinkle index, CCI, was scored from at least 25 contracting cells in each experimental condition, and CCI of the control sample was set equal to 1 in all stated results. Data from at least three independent experiments were graphed and analyzed for p value of statistical significance (t-test of two-samples assuming unequal variances). In the text and the figures, CCI values are presented as the average ± standard error of measurement. The difference between two CCI data sets was considered statistically significant when p<0.05.
Calpain inhibitors
Calpastat (abbreviated CALPST) is a synthetic 40 amino acid peptide previously developed in our laboratories and described to be a specific, cell-penetrating inhibitor of calpain activity and calpain-dependent in vivo cleavage of target proteins, including talin (Croce et al 1999; Potter et al 2003) . This peptide was synthesized and purified at Tufts University Core Facility, reconstituted to a 25 mM stock in 0.1 M HEPES, pH 7.4, and used at final concentrations of 5, 25 or 100 µM to treat pericyte cultures. The alanine-substituted mutant of CALPST, termed CALPST-ala, was also described above (Croce et al 1999) as an inactive control; this mutant was synthesized, prepared and used in the same fashion as CALPST.
Measurement of local elastic moduli with atomic force microscopy
An atomic force microscope (AFM; PicoPlus, Agilent Technology) was incorporated within an inverted optical microscope (IX81, Olympus) to enable facile positioning of AFM cantilevered probes above pericyte apical surfaces (See Fig. 4 ). All mechanical characterization experiments were conducted on living pericytes in full media at room temperature. Calibration of AFM cantilevers of nominal spring constant k = 0.01 nN/nm and nominal probe radius R = 25 nm (MLCT-AUHW, Veeco) was conducted as described previously (Thompson et al 2006) . Briefly, inverse optical lever sensitivity [nm/V] (InvOLS) was measured from deflectiondisplacement curves recorded on rigid glass substrates. Spring constants [nN/nm] of AFM cantilevers were measured via thermal activation recording of deflection, and the Fast Fourier Transform of cantilever free-end amplitude as a function of oscillation frequency was fitted as a harmonic oscillator to obtain this value. For each measurement of effective elastic moduli at any given location on any given cell, at least 30 replicate indentations were acquired to maximum depths of 10 nm. At least five cells were analyzed for each condition, and multiple indentation locations (i.e., wrinkle positions) were associated with each cell, as indicated in figure captions. Acquired probe deflection-displacement responses were converted offline (Scanning Probe Imaging Processor, Image Metrology), using measured spring constants and InvOLS, to force-depth responses. Effective elastic moduli E eff were calculated by applying a modified Hertzian model of spherical contact to the loading segment of the force-depth response, as detailed elsewhere (Lee et al 2010; Thompson et al 2005) with the scientific computing software Igor Pro (Wavemetrics). These E eff values represent the local stiffnesses of the subcellular domains probed in each experiment under contact loading, and are not intended to indicate the elastic properties of the entire cell or the Young's elastic modulus under uniaxial loading. In Fig. 4 , local cell stiffness values are normalized by E eff measured in untreated cells at subcellular domains located just above positions of substrata wrinkles. We have shown through previous AFM and fluorescence imaging that these locations correspond to regions of cell contraction that comprise F-actin stress fibers (Lee et al 2010) . Hereafter, subcellular domains corresponding to locations above wrinkles are denoted as "wrinkled domain" and subcellular domains corresponding to locations far from substrata wrinkles as "unwrinkled domain". This terminology is intended to contrast the local cell stiffness at sites of sustained contraction to that at sites remote from such visible contraction, within the same cell. As in the wrinkling index observations described above, only actively contracting cells (i.e., those producing substrata wrinkles) were analyzed.
Before elastic moduli measurement via AFM-enabled nanoindentation, x-and y-axes hystereses of the closed loop piezoscanner were calibrated to improve the positioning of AFM cantilevered probes on pericyte membranes and silicone substrata. The force that AFM cantilevers exerted on pericyte membranes during contact mode imaging did not exceed 500 pN, which was chosen to minimize the effect of mechanical contact between pericytes and AFM cantilevers during imaging that preceded mechanical characterization of subcellular domains.
Computed elastic moduli E eff are reported as average ± standard error of measurement. All statistical analyses were conducted with one-way ANOVA (Tukey analysis), with statistical significance in stiffness differences considered at p<0.05.
Results
Talin enhances pericyte contractility in calpain-dependent fashion
Previous work demonstrated a role for Rho GTP-dependent signaling in regulating pericyte and isoactin-dependent contraction in vitro (Kolyada, Riley and Herman 2003; Kutcher et al 2007) . In an effort to identify the upstream and downstream modulators that control contractile phenotype, we now focus on that the roles of key focal adhesion and cytoskeletal associated proteins in orchestrating pericyte contractile force exertion against adherent substrata. Since talin is a key FA component that binds integrin and F-actin, and because these integrincytoskeletal associations have been demonstrated to be calpain-sensitive (Franco et al 2004) , we were eager to learn whether overexpressing talin and vinculin or perturbing calpainmediated signaling might influence cellular contractility or stiffness. To directly assess the FAmediated and calpain-dependent regulation of force production in retinal pericytes, we utilized a single cell-based contractility assay of cells grown to subconfluence on a thin sheet of deformable silicone substrata (see Materials and Methods). In particular, we analyzed contractility of retinal pericytes (RP) overexpressing control enhanced green fluorescent protein (EGFP), EGFP-talin, an EGFP-calpain-resistant mutant talin L432G, or EGFPvinculin. Similarly, we took advantage of a Rho GTP expression plasmid, namely a dominant active mutant RhoA Q63L, co-expressed with control EGFP constructs.
In order to quantify contractile force transduction exerted by individual pericytes, we analyzed cell-derived deformation of the elastic substratum directly underlying each contractile cell. Real-time, digital imaging affords the opportunity to assess cellular dynamics and contractility. Reviewing static images derived from these living cell studies enables a quantitative analysis of the Cell Contractility Index (CCI; see Materials and Methods). The CCI proposed here takes into account not only the number but also the extent of substratum deformation events (i.e., local wrinkling of the substratum). Generally, we observed no preferential distribution of substrata wrinkles in relation to distal tips of extending filopodia, lamellar membrane ruffles or pseudopodial extensions engaging isotonically contracting cytoskeletal domains. With processes that are actively extending forward we observe that substrate deformation is confined to the well anchored regions, which are closer to the cell body (focal adhesion-rich domains). The accuracy of quantifying contractility in terms of CCI can further be validated by positive control experiments, wherein overexpression of dominant active RhoA Q63L demonstrated enhanced retinal pericyte contractility (CCI = 1.44 ± 0.18, p<0.05, Fig. 1b) as compared to the pericytes expressing vector alone. These findings are consistent with previous work describing RhoA Q63L expression in pericytes (Kutcher et al 2007) . Using CCI analysis of pericytes expressing constructs of interest and plated upon deformable silicone substrates, we observe that pEGFP-talin overexpression significantly enhances pericytes contractility (1.89 ± 0.12, p<4 × 10 −9 ), when compared to EGFP expressing control cells (Fig. 1B) . The point mutant of talin L432G, which has been demonstrated previously to be resistant to calpain cleavage (Franco et al 2004) , exhibits no statistically significant change in CCI (1.11 ± 0.12, p=0.44) as compared to the control EGFP-expressing cells. Interestingly, we observed that overexpression of EGFP-vinculin, another protein component of focal adhesions and a target of calpain cleavage, does not cause any statistically significant change in pericyte contractility (0.95 ± 0.11, p=0.77, Fig. 1B ) as compared to the control cells. These results indicate the important role of talin, but not vinculin, in modulating calpain-dependent cellular force transduction.
Calpain controls talin-enhanced, but not active RhoA-dependent pericyte contractility
Given that wild-type talin enhances pericyte contractility, and the calpain-resistant talin mutant L432G does not, we hypothesized that the CCI-enhancing effect of talin's overexpression would be reversible by calpain-specific pharmacologic inhibitors. To test this hypothesis, we took advantage of our previously described calpastatin-derived and cell-penetrating synthetic peptide, CALPASTAT (hereafter abbreviated as CALPST), which was reported to penetrate cells in vivo and specifically inhibit calpain activity (Croce et al 1999) . As a control, we used a cell-penetrating alanine-substituted mutant of CALPST (CALPST-ala), which was also previously described to be inactive in inhibiting calpain activity and unable to prevent cleavage of calpain targets such as talin (Croce et al 1999) . These calpain-specific inhibitors were added to living cell cultures following RP plating onto deformable substrata. As can be observed from Fig. 2 , CALPST concentrations of 5 and 25 µM do not have a statistically significant effect on CCI at 24, 48 or 96 hr. However, 100 µM CALPST inhibits CCI by 48 hr, down to 0.65 ± 0.06 of the untreated control (p <0.0004); note that 100 µM CALPST-ala control does not influence CCI (p <0.01). By 96 hr of 100 µM CALPST treatment, CCI inhibition is ~50% of control values (p<2 × 10 −7 ), with 100 µM CALPST-ala having no influence (p<6 × 10 −5 ). Thus, the 100 µM CALPST inhibitory CCI effects at both 48 and 96 hr are significantly different from CCI for corresponding untreated and CALPST-ala treated controls, and also from CCI for 25 µM CALPST at both treatment durations (p <0.01 and p <0.0005, respectively). Finally, we found that the inactive inhibitor CALPST-ala has no significant effect on CCI under any conditions tested (Fig. 2) . In summary, these results show that the cell-penetrating and calpainspecific inhibitor, CALPST, exhibits dose-and time-dependent inhibitory effects on pericyte contractility.
We next turned to studies aimed at revealing the calpain-dependence of talin-enhanced contractility. To this end, pericytes electroporated with pEGFP-talin, or pEGFP-talin L432G were left untreated or treated with CALPST as described (see Materials and Methods). As shown in Fig. 1b , when pericytes overexpressing EGFP-talin are treated with 25 µM CALPST for 24 hr, there is a 36% reduction in talin-induced contractility (0.64 ± 0.1, p<2 × 10 −6 ), as compared to untreated control cells. However, Fig. 3 shows that CALPST treatment does not alter pericyte CCI when cells are transfected with either control pEGFP vector (0.97 ± 0.12, p=0.85) or pEGFP-talin L432G (0.91 ± 0.09, p=0.82). Thus, the CALPST-dependent reversal of calpain-regulated contractility (in terms of CCI) corroborates data derived from our overexpression studies that indicated pericyte contractility to be talin-and calpain-dependent (Fig. 1) . Collectively, these findings reflect the important role that calpain plays in shaping talin-dependent contractility.
Considering that activated RhoA Q63L enhances pericyte contractile force production ( Fig. 1) and that RhoA has itself been reported to be a calpain substrate linked to cytoskeletal remodeling (Kulkarni, Goll and Fox 2002) , we then asked to what extent pericyte contractile force transduction induced by RhoA Q63L would be calpain-dependent. To address this question, we tested whether RhoA Q63L-induced contractility would be modulated when calpain activity is inhibited by CALPST. To this end, pericytes were co-electroporated with a transfection marker, pEGFP, and either pExv-RhoA Q63L or pExv control plasmid. Importantly, while RhoA Q63L increases contractility (1.44 ± 0.18, p<0.05; Fig. 1B ), pericyte CCI remains unaffected when RhoA L63-overexpressing cells are treated with CALPST (1 vs. 0.97 ± 0.13, p=0.52; Fig. 3 ). These results demonstrate that, unlike talin-enhanced contractility, RhoA-induced contractility is not calpain-sensitive.
Calpain controls contractile related stiffness measured by AFM nanoindentation
AFM-enabled nanoindentation allows for direct physical measurement of local elastic properties of living pericytes (Lee et al., 2010) , and thus enables correlations between cell contraction-induced silicone wrinkling and local cellular stiffness parameters (Fig. 4B) . We measured effective elastic moduli (E eff ) of subcellular regions located just above wrinkled domains of the deformable silicone substrata, corresponding to stress fiber-enriched subcellular domains, (Fig. 4A) as well as subcellular regions that are devoid of stress fibers, which are located above substrata that are not actively being deformed (i.e., divorced from wrinkled substratum regions, Fig. 4C ). Although these E eff are not intended to represent the mechanical stiffness of the entire cell, such experiments provide quantitative comparisons of the mechanical differences in contractile vs. noncontractile regions of the pericyte. These measurements evaluated regions of untreated cells, as well as cells treated with 100 µM CALPST or its inactive mutant CALPST-ala for 24 hr. In untreated cells, E eff measured on unwrinkled domains is lower (0.8 ± 0.05, p<0.05) as compared to wrinkled domains, thus correlating increased local cell stiffness with enhanced contractile strain. We have shown previously that, as expected, these regions of increased subcellular stiffness at wrinkled substrata are also regions of actin cytoskeletal bundles (Lee et al., 2010) . Interestingly, inhibition of calpain by CALPST causes a statistically significant increase in stiffness on wrinkled domains (1.3 ± 0.07, p<0.001 or 1.31 ± 0.07, p<0.001), as compared to such regions in untreated cells or in CALPST-ala treated cells, respectively (Fig. 4D) . Thus, the difference in E eff between wrinkled and unwrinkled domains in CALPST-treated cells is markedly enhanced (p<0.001) when compared to untreated cells (p<0.05). This effect of CALPST on subcellular stiffness is calpain-specific, since this effect is not observed in CALPST-ala treated cells. In addition, E eff on unwrinkled domains is essentially unchanged in either CALSPT or CALPST-ala treated cells, as compared to untreated controls (p=0.825, Fig. 4D ). This result indicates that inhibition of calpain activity leads to locally increased stiffness during cell contraction, whereas elastic properties of non-contractile regions remain unchanged.
Discussion
In this study, we demonstrate that calpain and talin play pivotal roles in modulating multiple aspects of pericyte-generated strains and contractile force transduction. In particular, we show that talin, but not its calpain-resistant mutant or its binding partner vinculin, contributes markedly to the extent of pericyte contractililty. These results, together with our earlier described calpain cleavage studies of endogenous talin (Croce et al., 1999) and of EGFP-talin (Franco et al., 2004) , point to the importance of calpain-mediated talin cleavage as a mechanism for regulating cellular contractility. We also demonstrate that calpain control of talin-enhanced contractility apparently operates upstream or in parallel to RhoA-regulated cytoskeletal remodeling since calpain inhibition can reverse talin-induced but, not RhoA L63-regulated pericyte contraction. Moreover, calpain's control over pericyte contractility is apparent whether using cell-penetrating calpain-specific inhibitors in single cell-based contractility assays or using direct measurement of subcellular stiffness via AFM-enabled nanoindentation. These findings significantly extend earlier studies aimed at understanding the Rho GTP-and cytoskeletal-dependent mechanisms that control pericyte contractility (Herman and D'Amore, 1985; Kolyada, Riley and Herman 2003; Kutcher et al 2007; Kutcher and Herman, 2009; Lee et al 2010) .
Calpain and talin control pericyte contractility
Using CCI, we observed that EGFP-talin overexpression significantly enhances pericyte contractility as compared to control cells overexpressing EGFP alone (Fig. 1) . These observations are consistent with the studies in which talin 1 has been shown to be necessary for reinforcement of integrin-mediated adhesion, linkage to actin cytoskeleton, and support of mechanotransduction in murine fibroblasts Zhang et al 2008) . On the contrary, we observed no change of contractility in pericytes overexpressing a point mutant of talin, L432G (Fig. 1b) . Indeed, endogenous talin and EGFP-talin have been demonstrated to be cleaved by calpain (Croce et al 1999 and Franco et al 2004, respectively) , whereas EGFPtalin L432G mutant has been shown to be resistant to calpain cleavage and to inhibit focal adhesion dynamics (Franco et al 2004) . Importantly, we observe differential effects of wildtype and mutant talin L432G overexpression on pericyte contractility. This cannot be attributed to differential localization of talin and this mutant in focal adhesions, as previous studies have confirmed comparable patterns of FA-specific localization for both wild-type and mutant talin L432G (Franco et al., 2004) . Additionally, talin and its L432G mutant exhibit comparable ability to interact with FAK and focal adhesion-targeted type I phospatidylinositol phosphate kinase (PIPK 66) as well as to activate integrin (Franco et al 2004) . In this context, our results are consistent with the calpain-dependent cleavage of talin as a critical step in controlling pericyte contractility, perhaps via modulating FA dynamics. This hypothesis is supported by the observable time-and dose-dependent CCI inhibitory effect of CALPST, but not of its mutant CALPST-ala (Fig. 2) . Observations of the time-dependent CALSPT inhibition on pericyte contractility (Fig. 2) can be related to previous reports describing calpain as an abundant and long-lived enzyme with half-life of approximately five days (Zhang, Lane and Mellgren 1996) . This may explain why low concentrations and early timepoints for CALPST treatment regimens (e.g., 25 µM at 24 hr) are seemingly below an observable threshold for inhibiting spontaneous pericyte contractility. Taken together, these data indicate that talin-and calpain-mediated signaling modulates pericyte contractility.
Talin, but not vinculin, enhances pericyte contractility in calpain-dependent fashion
Having established a critical role for calpain-dependent talin cleavage during cell contraction, we sought to determine whether vinculin would also play a role in contractile force transduction. By comparing effects of overexpressed talin to overexpressed vinculin in the deformable silicone substrata assay, we showed that vinculin overexpression does not alter pericyte contractility (Fig. 1b) , whereas talin overexpression does increase contractility. This finding is consistent with the report that calpain cleavage of talin is a rate-limiting step in controlling vinculin disassembly from FAs (Franco et al 2004) . In addition, despite the welldocumented presence of vinculin in all integrin-containing FA structures (Gilmore and Burridge 1996; Craig and Chen 2003; Zimerman, Volberg and Geiger 2004; Chen et al 2005) , it is widely reported that organization of FAs at the membrane critically depends on integrintalin binding but not on vinculin (Moulder et al 1996; Xu, Baribault and Adamson 1998) . Talin has also been demonstrated to be the most strongly bound component in the FA protein network (Lele et al 2008) . Furthermore, although vinculin has been suggested to contribute to strength of cell adhesion (Gallant, Michael and Garcia 2005) and to act as a target for calpain cleavage (Goll et al 2003; Weber et al 2009) , it has also been shown that mechanical stretching of talin unmasks its vinculin binding sites (del Rio et al 2009). Thus, it is likely that vinculin recruitment and activation in FAs (Chen, Choudhury and Craig 2006) depends strongly on presence and conformation of talin. Indeed, the present results demonstrate the central role that talin, but not vinculin, possesses in modulating pericyte contractility.
Calpain alters contractility by differential control of talin, but not of activated RhoA
The RhoA/Rho kinase pathway is critically involved in many aspects of cardiovascular physiology and pathophysiology (Loirand, Guerin and Pacaud 2006; Pacaud, Sauzeau and Loirand 2005) . Furthermore, since RhoA has been reported to be a calpain substrate (Goll et al 2003) , it was important to consider possible roles of calpain in RhoA-induced effects on pericyte contractility. Our previous work demonstrated that Rho GTP-dependent induction of pericyte contraction occurs in a αSMA-specific, but not non-muscle isoactin-dependent manner (Kolyada, Riley and Herman 2003; Kutcher et al 2007) . These earlier findings are consistent with our observations indicating that constitutively active RhoA Q63L enhances contractility. Importantly, however, we now appreciate that RhoA-driven pericyte contractility is not calpain-dependent, since contractility is not reversible by the calpain-specific inhibitor CALPST (Fig. 3) . Together, these data point to the possibility that active RhoA and calpain signal through the cytoskeletal network to influence contractile force transduction via parallel pathways. Indeed, the same constitutively active mutant of RhoA Q63L enhances bovine aortic endothelial (BAE) cell spreading, FA assembly and stress fiber formation even in the presence of the calpain inhibitor, calpeptin (Kulkarni et al 1999) . Similarly, calpain-dependent remodeling of FA components may influence adhesion-dependent and contractile mechanisms in an isoactin-dependent manner. For example, endothelial cells express non-muscle (β,γ) isoactins while pericytes express non-muscle (β,γ) and smooth muscle (α) contractile protein isoforms (Kutcher and Herman 2009; Herman and D'Amore 1985) . That pericyte and endothelial RhoA signaling is seemingly calpainin-sensitive suggests that earlier, upstream events modulate the calpain-, Rac-and RhoA-dependent signaling events that contribute to altered cell shape and contractile phenotype observed by us and by others (Bialkowska et al 2000) . This may also explain why we could not observe any increase in Rho-induced pericyte contractility in cells treated with CALPST; and that CALPST treatment did not reduce active RhoA-induced contractility, but could completely reverse talin-enhanced contractility as quantified by CCI (Fig. 3) . These data are consistent with a model which postulates that calpain operates upstream of active RhoA, enabling talin cleavage to differentially control contractile force transduction at mature focal adhesions.
Calpain modulates stiffness of pericyte contractile domains
Local effective stiffness of subcellular domains E eff was quantified in contractile pericytes via AFM-enabled indentation, both at cell locations just above the substrata wrinkles ("wrinkled domains") and at cell locations remote from those contractile zones ("unwrinkled domains"). We found that E eff of the stress fiber-enriched pericyte domains at substrata wrinkles was greater than the subcellular stiffness far from such wrinkles (Fig. 4) , as is consistent with the stress-fiber enrichment at the "wrinkled domains". Importantly, E eff markedly increased in response to calpain inhibition by CALPST (Fig. 4) . CALPST also decreased the number of contractile substrata deformations per cell as quantified by CCI (Fig. 2) , viz. local cell stiffness at sites of substrata wrinkling was increased, but the ability of cells to deform their underlying substrata was decreased in response to calpain inhibition.
The observed increase in stiffness of the subcellular contractile regions in response to calpain inhibition can be explained readily by the regulatory role(s) that calpain-mediated remodeling of focal adhesion-associated cytoskeletal proteins play in modifying these extracellular matrixinteracting, cytoskeletal-plasma membrane contact zones. As has been shown by our laboratory (Potter et al, 1998) and others (Franco et al, 2004) , calpain-dependent remodeling of the actinassociated cytoskeleton is needed for protrusion formation and cell spreading as well as remodeling the focal contact-enriched membrane anchoring domains needed to disengage rearward adhesions such that cellular translocation can be fostering (by transiently disengaging focal adhesions via calpain-mediated talin proteolysis (Franco et al 2004) . Results of our studies not only support these earlier findings, but demonstrate that inhibition of calpain-dependent cytoskeletal (talin) remodeling gives rise to enhanced stability of existing adhesion complexes, a greater persistence of the actin-rich stress fibers and a locally elevated mechanical stiffness linked to decreased talin and focal adhesion turnover. Further, we reason that there are likely to be indirect effects of calpain inhibition on cytoskeletal effectors, which might include a potential increase in RhoA activation through effects on the guanine exchange or activating proteins (GEF/GAP), as has been suggested by others (Kulkarni, Goll and Fox 2002; Mammoto, Huang and Ingber 2007; Miyazaki, Honda and Ohata 2009) . Such increased RhoA activation would induce higher contractile force production outside of the calpain-regulated cytoskeletal effector pathways involved in regulating cell shape and motility since CALPST treatment of living pericytes has no effect on RhoA-regulated cytoskeletal remodeling (Fig.  3) . On the other hand, there is one report suggesting opposing effects of calpain on RhoAdependent cytoskeletal remodeling (Gonscherowski et al 2006) , which may be cell-or contractile protein isoform-specific since RhoA-and calpain-dependent mechanisms, which control contractility and/or force transduction in non-muscle or smooth muscle-like cells may not be identical (Herman and D'Amore, 1985; Kolyada et al 2003; Kutcher and Herman 2007; Durham and Herman 2009 ).
Given the dynamic nature pericyte-driven deformation of elastic substrata, the observations that CALPST treatment of living cells yields differential effects on cytoskeletal-dependent contractile events, i.e. decreased CCI and increased E eff , suggests that calpain regulates a dynamic interplay involved in generating or sustaining those cellular forces needed for isotonically-and/or isometrically-contracting cytoplasmic domains. For example, we seldom observe deformed substrata underlying regions of advancing cytoplasm actively engaged in isotonically-contracting F-actin rich cytoplasmic domains (distal reaches of pseudopods, filapods and membrane ruffles). This is in stark contradistinction to the actively deformed zones of elastic substrata beneath domains that we posit to be engaged in isometric contraction where force transduction is occurring in the absence of stress fiber length or cell shape changes. We reason that such a calpain-controlled balance in pericyte contractility likely depends on the dynamics of FA assembly/turnover, which has been shown to calpain-and talin-dependent (Franco et al 2004) . Moreover, our results also suggest a controlling role for calpain in a positive feedback loop existing between force transduction and FA stabilization (Balaban et al 2001; Bershadsky et al 2006; Burridge and Chrzanowska-Wodnicka 1996) . Indeed, this dynamically reciprocal signaling loop could likely be controlled by calpain, which cleaves talin and fosters β integrin subunit dissociation from other FA-and cytoskeletal-associating proteins (Franco and Huttenlocher 2005) . However, such control could be lost with calpain inhibition, resulting in (i) non-cleaved talin, (ii) inhibition of FA turnover and (iii) enhanced local stiffening. This hypothesis is consistent with our observations of decreased CCI and increased E eff above or "on" substrata wrinkles in response to calpain inhibitor CALPST. In addition, the observation of increased stiffness (E eff "on" wrinkles) is consistent with the reported enlargement of paxillin-and vinculin-containing FAs caused by talin L432G expressed in talin1 null cells (Franco et al 2004) , which could likely lead to FA stabilization, increased association of filamentous actin, and thus be coupled with increased magnitude of contractile force. Our combined data suggest a preliminary model wherein increases in Rho GTP-dependent cytoskeletal contractile events anchored at the FA are countered via calpain-dependent modulation of cellular mechanotransduction. Thus, by selectively targeting key FA-associated cytoskeletal substrates, such as talin, pericytes' control of contractile forces against adherent substrata (extracellular matrix and basement membrane) or adjacent microvascular endothelial cells (cell-cell association) could be regulated. More detailed studies of the kinetics and distribution of contractile forces, as well as of calpain-dependent signaling pathways and mechanisms involved in generation of these forces, are needed to further elucidate and validate such a regulatory model.
Calpain control of cellular contractility and human pathogenesis
In addition to identifying calpain and talin functional interactions as an important regulatory mechanism of cell contractility in general, our results offer insights into phenomena that underlie microvascular disorders such as in retinopathies. The calpain pathway has been implicated in as a mechanism of apoptotic retinal cell death produced by elevated intraocular pressure and hypoxia leading to retinal degenerations associated with glaucoma and retinitis pigmentosa (Paquet-Durand, Johnson and Ekstrom 2007; Azuma and Shearer 2008) . Moreover, deregulated contractility of pericytes has been postulated as a potential, chemomechanically transduced cause of microvascular endothelial hyperproliferation and perturbed tone in pathogenesis of diabetic and age related retinopathies (Kutcher and Herman 2009; Kutcher et al 2007) . Additionally, deregulated contractile force transduction seems an even more relevant target of investigation and potential therapeutic interventions, as we have most recently demonstrated that the strains exerted by pericytes onto substrata can be sufficient to alter the effective elastic moduli of basement membrane; this substrata stiffening would provide indirect modulation of the EC mechanical microenvironment, in addition to the direct mechanical strain pericytes can exert via contraction (Lee et al 2010) . Further investigation into the effects of FA manipulations on pericyte-dependent EC growth control would validate this hypothesis of such a mechanism contributing to microvascular disorders. Bovine retinal pericytes were electroporated either with plasmids encoding control EGFP and fusion of EGFP-talin, EGFP-talin L432G (calpain-resistant mutant, or co-transfected (in 1:4 ratio) with plasmids encoding EGFP and RhoA Q63L (dominant active mutant). On next day, transfected pericytes were seeded onto deformable silicone substrata. After 24 h live GFPpositive cells were evaluated by microscopy. On next day, transfected pericytes were seeded onto deformable silicone substrata, and either left untreated or treated with calpain inhibitor CALPST at 25 µM final concentration for 24 h. Contractility of samples was analyzed for Cell Contractility Index (CCI) and normalized to untreated EGFP control equaled to 1. Asterisk (*) indicates statistically significant difference between CALPST treated EGFP-talin and untreated EGFP-talin (p<2E-6). CALPST treatment of other cultures does not cause statistically significant differences, as compared with their corresponding untreated controls. Left (A) and right (C) images show optical microscopy images of the cantilever positioned directly above and far from wrinkled regions of the silicone substrata, respectively (on-wrinkle and off-wrinkle, respectively). Black arrowheads indicate wrinkles observable in silicone substrate. Central diagram (B) demonstrates the experimental set-up, wherein pericytes were grown on deformable silicone substrata and exhibited actin stress fibers (also marked by the star in left inset); pericyte contractile forces deformed or wrinkled the substratum, and indentation of subcellular regions was conducted near and far from regions of visible substrata contraction. Insets in (A) -(C) show AFM deflection images of pericytes and underlying silocone substrata with cell-generated wrinkle deformations. (D) Subcellular stiffness expressed as indentation effective elastic moduli E eff at on-and off-wrinkle positions, as a function of exposure to calpain inhibitor CALPST (100 µM final concentration, 24 h). At least five cells were analyzed per condition, and data are normalized by the value of E eff for the untreated cells on-wrinkle stiffness. Asterisk (*) indicates statistically significant difference in E eff between on-wrinkle and off-wrinkle locations (p<0.05); and plus sign ( ‡) indicates statistically significant differences in E eff for CALPST-treated as compared to untreated or CALPST-ala cells (p<0.001); double asterisk (**) indicates statistically significant difference in E eff between CALPST treated on-wrinkle and off-wrinkle (p<0.001). Scale bar = 20 µm.
